Status:
COMPLETED
PROMUS™ Element™ Everolimus-Eluting Coronary Stent System European Post-Approval Surveillance Study
Lead Sponsor:
Boston Scientific Corporation
Collaborating Sponsors:
Pharmaceutical Research Associates
Medidata Solutions
Conditions:
Coronary Heart Disease
Eligibility:
All Genders
Brief Summary
The goal of the PROMUS™ Element™ Everolimus-Eluting Coronary Stent System European Post- Approval Surveillance Study is to evaluate real world clinical outcomes data for the PROMUS™ Element™ Coronary ...
Eligibility Criteria
Inclusion
- According to Instructions For Use
Exclusion
- Contraindications according to Instructions for Use
Key Trial Info
Start Date :
June 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
1010 Patients enrolled
Trial Details
Trial ID
NCT01148329
Start Date
June 1 2010
End Date
December 1 2016
Last Update
February 2 2017
Active Locations (40)
Enter a location and click search to find clinical trials sorted by distance.
1
Allgemeines Krankenhaus der Stadt Linz
Linz, Austria, A-4020
2
Medizinische Universität Wien
Vienna, Austria, A-1090
3
Klinikum Wels-Grieskirchen
Wels, Austria, 4600
4
Virga Jesse Ziekenhuis
Hasselt, Belgium, 3500